JAMES, JOYCE K.,EICHELBERGER, SHAWN R.,SAVALL, TRACI L.
申请号：
PL08847113
公开号：
PL2205244T3
申请日:
2008.11.07
申请国别(地区):
PL
年份:
2014
代理人:
摘要：
Provided herein are methods of administering N -(5- tert -butyl-isoxazol-3-yl)- N '-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Further, pharmaceutical formulations are provided. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.
